Estrone

CPT: 82679
Print Share

Synonyms

  • E1

Special Instructions

Nonpregnant patients only.


Expected Turnaround Time

4 - 5 days


Related Documents


Specimen Requirements


Specimen

Serum from a serum separator tube


Volume

0.6 mL


Minimum Volume

0.4 mL (Note: This volume does not allow for repeat testing.)


Container

Gel-barrier serum separator tube; red top tubes (without gel barrier) should not be used


Storage Instructions

Room temperature


Stability Requirements

Temperature

Period

Room temperature

14 days

Refrigerated

14 days

Frozen

14 days

Freeze/thaw cycles

Stable x3


Causes for Rejection

Sample collected with any tube other than a gel barrier (serum separator) tube


Test Details


Use

Evaluate postmenopausal vaginal bleeding due to peripheral conversion of androgenic steroids. Increased estrone levels may be associated with increased levels of circulating androgens and their subsequent peripheral conversion.


Methodology

Enzyme immunoassay (EIA)


Reference Interval

See table.

Age (y)

Male (pg/mL)1,2

Female (pg/mL)1,2

Tanner Stage I

5−17

4−29

Tanner Stage II

10−25

10−33

Tanner Stage III

15−25

15−43

Tanner Stage IV

15−45

16−77

Tanner Stage V

20−45

29−105

Adults

0−174

Adult (Premenopausal): 27−231

Menstrual Cycle (1-10 days): 19−149

Menstrual Cycle (11-20 days): 32−176

Menstrual Cycle (21-30 days): 37−200

Adult (Postmenopausal): 0−125


Additional Information

Estrone (E1) is a steroid, a weak estrogen, and a minor female sex hormone.3,4 Estrone is one of three major endogenous estrogens, the others being estradiol and estriol.3,4 Like the other estrogens, estrone is synthesized from cholesterol and secreted mainly from the gonads, though they can also be formed from adrenal androgens in adipose tissue. Estrone is primarily derived from metabolism of androstenedione in peripheral tissues, especially adipose tissues. Individuals with obesity have increased conversion of androstenedione to estrone, leading to higher concentrations. Estrone can be converted into estradiol and serves mainly as a precursor or metabolic intermediate of estradiol. In addition, an increase in the ratio of estrone to estradiol may be useful in assessing menopause in women.


Footnotes

1. Tietz NW, ed. Clinical Guide to Laboratory Tests. 4th ed. Philadelphia, Pa: WB Saunders Co; 2006:378-379.
2. Estrone RIA DSL8700-FOC-02 [package insert]. Beckman Coulter/ImmunoTech; 2018.
3. Coelingh Bennink HJT. Are all estrogens the same? Maturitas. 2004 Apr 15;47(4):269-275.15063479
4. Kuhl H. Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric. 2005 Aug;8 Suppl 1:3-63.16112947

References

Gruber CJ, Tschugguel W, Schneeberger C, Huber JC. Production and actions ofestrogens. N Engl J Med. 2002 Jan 31;346(5):340-352.11821512
Kronenberg H, Williams HR. The physiology and pathology of the female reporductive axis. In: Williams Textbook of Endocrinology. 11th ed. Philadelphia, Pa: Saunders/Elsevier; 2008:541-614.
Nelson LR, Bulun SE. Estrogen production and action. J Am Acad Dermatol. 2001 Sep;45(3 Suppl):S116-24.11511861

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
004564 Estrone, Serum 2258-2 004564 Estrone, Serum pg/mL 2258-2

For Providers

Please login to order a test

Order a Test

© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf